Venus Remedies Limited is an India-based dosage injectable manufacturer. The Company operates in pharmaceutical formulation and is engaged in manufacturing and trading of medicines. The Company products include Sulbactomax, Potentox, Tobracef, Vancoplus, and ACHNIL. During the fiscal year ended March 31, 2012 (fiscal 2012), the Company introduced nanotechnology-based, ready-to-use single vial Docetaxel in the domestic market under the Taxedol brand. In fiscal 2012, the Company developed a product pipeline for breast and ovarian cancer using this technology. In fiscal 2012, the Company completed Phase I and II clinical trials for VRP1620, a cancer detection molecule. In July 2011, the Company launched a formulation, ACHNIL brand of Aceclofenac injection in India. The Company has manufacturing facilities in Panchkula, Baddi, and Werne.